About Zinc finger protein 69 homolog
Zinc finger protein 69 homolog (ZFP69) is a protein
from Homo sapiens identified by UniProt accession
Q49AA0, 526 residues long.
MolForge cross-references it against 0 known binders and
15 disease associations.
Target properties
| Protein name | Zinc finger protein 69 homolog |
| UniProt accession | Q49AA0 |
| Gene | ZFP69 |
| Organism | Homo sapiens |
| Length | 526 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (15)
Diseases linked to this target (Open Targets).
- acute myeloid leukemia · score 0.18
- pancreatic adenocarcinoma · score 0.14
- lymphocyte count · score 0.09
- FTH1-related iron overload · score 0.04
- hemochromatosis type 5 · score 0.04
- diabetes mellitus · score 0.03
- heel bone mineral density · score 0.03
- Obesity · score 0.02
- type 2 diabetes mellitus · score 0.02
- Insulin resistance · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q49AA0-F1 | alphafold | PREDICTED | 65.27 | — |
Amino-acid sequence (526 residues)
MPQQLLITLP TEASTWVKLQ HPKKAVEGAP LWEDVTKMFE GEALLSQDAE DVKTQRESLE DEVTPGLPTA ESQELLTFKD ISIDFTQEEW GQLAPAHQNL YREVMLENYS NLVSVGYQLS KPSVISQLEK GEEPWMAEKE GPGDPSSDLK SKIETIESTA KSTISQERLY HGIMMESFMR DDIIYSTLRK VSTYDDVLER HQETCMRDVR QAILTHKKRV QETNKFGENI IVHSNVIIEQ RHHKYDTPTK RNTYKLDLIN HPTSYIRTKT YECNICEKIF KQPIHLTEHM RIHTGEKPFR CKECGRAFSQ SASLSTHQRI HTGEKPFECE ECGKAFRHRS SLNQHHRTHT GEKPYVCDKC QKAFSQNISL VQHLRTHSGE KPFTCNECGK TFRQIRHLSE HIRIHTGEKP YACTACCKTF SHRAYLTHHQ RIHTGERPYK CKECGKAFRQ RIHLSNHKTV HTGVKAYECN RCGKAYRHDS SFKKHQRHHT GEKPYECNEC GKAFSYNSSL SRHHEIHRRN AFRNKV
Explore Zinc finger protein 69 homolog with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets